Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis.
Berend J. van der Wilk(Erasmus MC Cancer Institute), Guillaume Piessen(Centre Hospitalier Universitaire de Lille), Daan Nieboer(Erasmus MC), Sung‐Bae Kim(Ulsan College), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Heidi Furlong(The University of Texas MD Anderson Cancer Center), Jaffer A. Ajani(The University of Texas MD Anderson Cancer Center), Sjoerd M. Lagarde(University of Amsterdam), Rita Alfieri(Istituto Oncologico Veneto), Jong H. Kim(Seoul National University), Ben M. Eyck(Erasmus MC Cancer Institute), T. N. Walsh(Connolly Hospital Blanchardstown), Carlo Castoro(Humanitas University)
Cited by 39
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.7k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.1k